標(biāo)題: Titlebook: Non-coding RNAs in Cardiovascular Diseases; Junjie Xiao Book 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license [打印本頁] 作者: 凝固 時間: 2025-3-21 16:33
書目名稱Non-coding RNAs in Cardiovascular Diseases影響因子(影響力)
書目名稱Non-coding RNAs in Cardiovascular Diseases影響因子(影響力)學(xué)科排名
書目名稱Non-coding RNAs in Cardiovascular Diseases網(wǎng)絡(luò)公開度
書目名稱Non-coding RNAs in Cardiovascular Diseases網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Non-coding RNAs in Cardiovascular Diseases被引頻次
書目名稱Non-coding RNAs in Cardiovascular Diseases被引頻次學(xué)科排名
書目名稱Non-coding RNAs in Cardiovascular Diseases年度引用
書目名稱Non-coding RNAs in Cardiovascular Diseases年度引用學(xué)科排名
書目名稱Non-coding RNAs in Cardiovascular Diseases讀者反饋
書目名稱Non-coding RNAs in Cardiovascular Diseases讀者反饋學(xué)科排名
作者: 把手 時間: 2025-3-21 22:24
https://doi.org/10.1007/978-981-15-1671-9Cardiovascular diseases; Non-coding RNAs; Cardiovascular system; biomarkers and therapeutic implication作者: 賞心悅目 時間: 2025-3-22 03:53 作者: Tidious 時間: 2025-3-22 07:30
Non-coding RNAs in Cardiovascular Diseases978-981-15-1671-9Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: Indelible 時間: 2025-3-22 11:22
Junjie XiaoProvides the latest research progress on non-coding RNAs in cardiovascular diseases.Covers many aspects in the research of non-coding RNAs and cardiovascular system.Involves future prospects作者: 腐蝕 時間: 2025-3-22 15:04 作者: Indelible 時間: 2025-3-22 20:28
An Overview of Non-coding RNAs and Cardiovascular Systems and miRNAs involvement in the cardiovascular diseases is also addressed. Detailed functional analysis of this vast group of highly regulatory molecules will be promising for shaping future drug discoveries.作者: 發(fā)牢騷 時間: 2025-3-22 22:39 作者: PATRI 時間: 2025-3-23 03:07
Involvement of Epigenetic Control and Non-coding RNAs in Cardiovascular Systemocus of present chapter is to decipher the role of epigenetics in CVDs and its potential to be used in risk assessment or as biomarkers in devising and deploying better diagnosis and treatment for different CVDs.作者: 問到了燒瓶 時間: 2025-3-23 07:58
Non-coding RNAs and Cardiac Agingances of ncRNAs in cardiac aging will be provided. The lessons learned from ncRNAs and cardiac aging studies would bring new insights into the regulatory mechanisms ncRNAs as well as treatment of aging-related cardiovascular diseases.作者: 效果 時間: 2025-3-23 11:30
Noncoding RNAs and Heart Failureted to well-known HF risk factors, such as hypertension, diabetes etc. In this review, we sought to summarize current knowledge about noncoding RNAs and noncoding RNAs mediated regulation of HF and its risk factors.作者: Inflamed 時間: 2025-3-23 16:39 作者: 浪費物質(zhì) 時間: 2025-3-23 18:50
Online Databases and Non-coding RNAs in Cardiovascular Diseasesr advances in cardiovascular disease. With the development of sequencing and computer technology, more and more databases can be easily obtained on the internet. In another part of this chapter, we will summarize some commonly used non-coding RNA databases, which can be easily and quickly used for relevant research.作者: 知識分子 時間: 2025-3-24 00:13
Comprehensive Overview of Non-coding RNAs in Cardiac DevelopmentDNA and involved in the proper formation of the heart. In this chapter, we will summarize the current state of the art on the roles of three major forms of ncRNAs [microRNAs (miRNAs), long ncRNAs (lncRNAs) and circular RNAs (circRNAs)] in orchestrating the four sequential phases of cardiac organogenesis.作者: 現(xiàn)實 時間: 2025-3-24 04:32 作者: 提名 時間: 2025-3-24 07:37 作者: 有斑點 時間: 2025-3-24 12:49 作者: 闖入 時間: 2025-3-24 16:53
RNA Binding Proteins and Non-coding RNA’s in Cardiovascular Diseasesotential of miRNAs to treat a disease. This review embodies the recent work done in the field of miRNA and its role in cardiovascular disease as diagnostic biomarker as well as therapeutic agents. In addition the review highlights the future of miRNAs as a potential therapeutic target and need of de作者: plasma 時間: 2025-3-24 20:50 作者: 傻 時間: 2025-3-25 02:01 作者: malign 時間: 2025-3-25 07:09
Non-coding RNAs in Cardiac Regenerationf hematopoietic c-kit-positive cells derived from bone marrow into the infarcted heart [3]. However, in sharp contrast, more recent evidence emerged demonstrating that these hematopoietic stem cells only differentiate into cells down the hematopoietic lineage rather than into cardiomyocytes [4, 5], 作者: 預(yù)兆好 時間: 2025-3-25 08:25
Role of Non-coding RNA in Diabetic Cardiomyopathys of non-coding RNAs in the pathological process of DCM and showed the future possibilities of these non-coding RNAs in DCM treatment. In this chapter, we summarized the present advance of the researches in this filed and raised the concern and the prospect in the future.作者: Bother 時間: 2025-3-25 14:55 作者: 臭了生氣 時間: 2025-3-25 18:29
0065-2598 ture prospects. It is particularly useful for researchers and students in the field of non-coding RNA and cardiovascular biology, as well as for cardiologists, pharmacologists and physiologists..978-981-15-1673-3978-981-15-1671-9Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: 講個故事逗他 時間: 2025-3-25 21:46 作者: TOXIN 時間: 2025-3-26 02:50
Marina C. Costa,André F. Gabriel,Francisco J. Enguita作者: TRAWL 時間: 2025-3-26 06:31
André F. Gabriel,Marina C. Costa,Francisco J. Enguita作者: 放肆的我 時間: 2025-3-26 11:36
Wanlin Jiang,Devendra K. Agrawal,Chandra Shekhar Boosani作者: 神經(jīng) 時間: 2025-3-26 15:36
C. F. T. van der Ven,B. C. R. Hogewoning,A. van Mil,Joost P. G. Sluijter作者: FAR 時間: 2025-3-26 17:18 作者: 良心 時間: 2025-3-26 22:30
Tarik Smani,Isabel Mayoral-Gonzalez,Isabel Galeano-Otero,Isabel Gallardo-Castillo,Juan A. Rosado,Ant作者: VALID 時間: 2025-3-27 01:59
An Overview of Non-coding RNAs and Cardiovascular Systemhorizon in the field of molecular medicines and in the development of early diagnostic markers. Non-coding RNAs are the highly functional and vibrant nucleic acids and are known to be involved in the regulation of endothelial cells, vascular and smooth muscles cells, cardiac metabolism, ischemia, in作者: 荒唐 時間: 2025-3-27 08:24
Bioinformatics Research Methodology of Non-coding RNAs in Cardiovascular Diseasesof pathologies. In cardiovascular diseases, the role of specific families of RNA transcripts belonging to the group of the non-coding RNAs started to be unveiled in the last two decades. The knowledge of the functional rules and roles of non-coding RNAs in the context of cardiovascular diseases is a作者: Minutes 時間: 2025-3-27 12:00 作者: 火光在搖曳 時間: 2025-3-27 14:49 作者: 客觀 時間: 2025-3-27 19:55 作者: flutter 時間: 2025-3-27 23:00
Involvement of Epigenetic Control and Non-coding RNAs in Cardiovascular Systemng to pathophysiology and genetics of CVDs have helped in prevention, diagnosis and treatment of diseases, there are still lacunas in our knowledge. So, novel tools that can define genomic regulation under different conditions are needed to bridge this gap. ‘Epigenetic’ mechanism helps the cells to 作者: Institution 時間: 2025-3-28 05:18
Non-coding RNAs as Epigenetic Gene Regulators in Cardiovascular Diseasesng normal or specific developmental stages of the organisms. Primarily, three different mechanisms have been identified to participate in epigenetic gene regulations which include, DNA methylation, non-coding RNA species (microRNAs [miRNA], and long non-coding RNAs [LNC-RNA]) and histone modificatio作者: Substance-Abuse 時間: 2025-3-28 10:13
Non-coding RNAs in Physiological Cardiac Hypertrophyon, RNA maturation and protein translation, participating in a variety of physiological and physiological processes. NcRNAs have important functions, and are recently one of the hotspots in biomedical research. Cardiac hypertrophy is classified into physiological cardiac hypertrophy and pathological作者: 長矛 時間: 2025-3-28 13:57 作者: 攀登 時間: 2025-3-28 17:46 作者: 津貼 時間: 2025-3-28 19:06 作者: Exonerate 時間: 2025-3-28 22:55
Noncoding RNAs and Heart Failurep effecitive therapies to treat HF. Recently, scientists and clinicians identified that noncoding RNAs play important roles in pathogenesis of HF. Some of noncoding RNAs can serve as novel biomarkers for HF and some of them contribute to the progression of HF. In addition, noncoding RNAs can be rela作者: 感情脆弱 時間: 2025-3-29 03:58
Non-coding RNAs and Pathological Cardiac Hypertrophyity and high mortality. Myocardial hypertrophy (MH) is a common pathological process of various cardiovascular diseases and is considered as an independent risk factor for increased cardiovascular morbidity and mortality. Therefore, it is particularly important to understand its pathological mechani作者: locus-ceruleus 時間: 2025-3-29 08:20 作者: farewell 時間: 2025-3-29 15:27
Non-coding RNAs and Ischemic Cardiovascular Diseases supply and demand, leading to morbidity and mortality across the worldwide. Prompt diagnostic and prognostic represents key factors for the treatment and reduction of the mortality rate. Therefore, one of the newest frontiers in cardiovascular research is related to non-coding RNAs (ncRNAs), which 作者: Scleroderma 時間: 2025-3-29 18:31
8樓作者: 高度表 時間: 2025-3-29 23:26
8樓作者: idiopathic 時間: 2025-3-30 02:58
8樓作者: Senescent 時間: 2025-3-30 05:46
9樓作者: 歡笑 時間: 2025-3-30 08:29
9樓作者: 半身雕像 時間: 2025-3-30 14:01
9樓作者: 減至最低 時間: 2025-3-30 17:03
9樓作者: achlorhydria 時間: 2025-3-30 21:37
10樓作者: Occupation 時間: 2025-3-31 02:50
10樓作者: 惰性女人 時間: 2025-3-31 05:15
10樓作者: Narrative 時間: 2025-3-31 12:58
10樓
